Dr Michael Levy

Guest Contributor
January 29, 2001

Dr Michael Levy has resigned as VP research and chief medical office of Glaxo Wellcome Canada. Levy, considered one of the shining stars of the Canadian pharmaceutical sector, has accepted a position with Tularik Inc, a biotechnology firm based in San Francisco CA. Levy will assume the duties of VP development and chief medical officer, leading Tularik's development activities with a focus on new drug approvals. As a member of the senior management team, he will also play a role in the company's strategic direction. The new position represents a marked change from Levy's duties at Glaxo Wellcome, which were l


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.